U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
NAVICIXIZUMAB
INN   USAN   WHO-DD  
INN   USAN  
Official Name English
navicixizumab [INN]
Preferred Name English
IMMUNOGLOBULIN G2-KAPPA, ANTI-(HOMO SAPIENS DLL4(DELTA-LIKE 4)) AND ANTI-(HOMO SAPIENS VEGFA (VASCULAR ENDOTHELIAL GROWTH FACTOR A,VEGF-A, VEGF)), HUMANIZED AND CHIMERIC MONOCLONAL ANTIBODY, BISPECIFIC
Common Name English
Navicixizumab [WHO-DD]
Common Name English
NAVICIXIZUMAB [USAN]
Common Name English
OMP-305B83
Code English
Code System Code Type Description
SMS_ID
300000021848
Created by admin on Mon Mar 31 23:36:03 GMT 2025 , Edited by admin on Mon Mar 31 23:36:03 GMT 2025
PRIMARY
FDA UNII
1W14T9L25W
Created by admin on Mon Mar 31 23:36:03 GMT 2025 , Edited by admin on Mon Mar 31 23:36:03 GMT 2025
PRIMARY
DRUG BANK
DB12634
Created by admin on Mon Mar 31 23:36:03 GMT 2025 , Edited by admin on Mon Mar 31 23:36:03 GMT 2025
PRIMARY
USAN
DE-134
Created by admin on Mon Mar 31 23:36:03 GMT 2025 , Edited by admin on Mon Mar 31 23:36:03 GMT 2025
PRIMARY
NCI_THESAURUS
C119620
Created by admin on Mon Mar 31 23:36:03 GMT 2025 , Edited by admin on Mon Mar 31 23:36:03 GMT 2025
PRIMARY
INN
10220
Created by admin on Mon Mar 31 23:36:03 GMT 2025 , Edited by admin on Mon Mar 31 23:36:03 GMT 2025
PRIMARY
CAS
1638338-43-8
Created by admin on Mon Mar 31 23:36:03 GMT 2025 , Edited by admin on Mon Mar 31 23:36:03 GMT 2025
PRIMARY
ACTIVE MOIETY
NAVICIXIZUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966